DongKoo Bio & Pharma Co. Ltd. (006620) — Free Cash Flow Generation Index
DongKoo Bio & Pharma Co. Ltd. (006620) has a Free Cash Flow Generation Index of -0.17x as of June 2026. Free cash flow of ₩-756.72 Million represents 0% of operating cash flow (₩4.46 Billion). Explore 006620 capital reinvestment ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
DongKoo Bio & Pharma Co. Ltd. Free Cash Flow Generation Index (2015–2024)
Historical FCF Generation Index trend for DongKoo Bio & Pharma Co. Ltd. across 9 annual periods. For the full cash flow conversion analysis, see 006620 cash generation efficiency.
Annual Free Cash Flow Generation for DongKoo Bio & Pharma Co. Ltd. (2015–2024)
Year-by-year Free Cash Flow Generation Index for DongKoo Bio & Pharma Co. Ltd.. Check 006620 cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (KRW) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2024 | -0.47x | ₩-8.12 Billion | ₩17.34 Billion | ₩25.46 Billion | ▲ +86.4% |
| 2023 | -3.45x | ₩-12.38 Billion | ₩3.59 Billion | ₩15.97 Billion | ▼ -1111.1% |
| 2022 | 0.34x | ₩5.74 Billion | ₩16.82 Billion | ₩11.08 Billion | ▼ -50.8% |
| 2021 | 0.69x | ₩12.43 Billion | ₩17.90 Billion | ₩4.27 Billion | ▲ +156.3% |
| 2020 | 0.27x | ₩2.03 Billion | ₩7.49 Billion | ₩5.27 Billion | ▲ +208.5% |
| 2019 | -0.25x | ₩-2.53 Billion | ₩10.14 Billion | ₩8.77 Billion | ▼ -123.0% |
| 2017 | 1.09x | ₩10.32 Billion | ₩9.51 Billion | ₩810.51 Million | ▼ -28.6% |
| 2016 | 1.52x | ₩19.14 Billion | ₩12.59 Billion | ₩6.55 Billion | ▲ +14.0% |
| 2015 | 1.33x | ₩9.25 Billion | ₩6.93 Billion | ₩2.32 Billion | — |